Home › Trial NCT01390818
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
- Trial IDNCT01390818
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorEMD Serono
- Enrollment146
- Start date2011-05
- ConditionsLocally Advanced Solid Tumor · Metastatic Solid Tumor · Breast Cancer · Non Small Cell Lung Cancer · Melanoma · Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.